The ad begins with a family posing for photos while a fast-moving piano riff plays, reminiscent of the title sequence of the ...

Hims & Hers is returning to the Super Bowl — one year after its debut spot kicked up a storm of controversy. The telehealth ...

Narrated by Common, Hims & Hers' 2026 Super Bowl ad positions affordability as part of the solution to the income disparities shaping health outcomes.

"We fully expect this will ruffle some feathers," Hims & Hers chief design officer, Dan Kenger, told Business Insider.

In less than two weeks, more than 120 million people are expected to tune into the biggest advertising moment of the year: the Super Bowl. Companies shelled out about $8 million for 30 seconds of air ...

The telehealth company is back in the fourth quarter of the Big Game, a year after its weight-loss ad drew regulatory and ...

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, announced that it’s heading back to the Big Game this year. On February 8th, Hims & Hers will follow up ...

Last year, Hims & Hers put out a Super Bowl ad—the first for the telehealth giant—that sparked both support and outrage for the way it claimed that Big Pharma prices GLP-1s “ for profits, not patients ...

Advanced cancer detection, hormone therapies and microdoses of GLP-1 sound like medical treatments for the rich and chic. One company is taking them to the Super Bowl so that anyone can try them. Hims ...

This week, Hims & Hers’ (NYSE:HIMS) recent Super Bowl ad campaign was at least twice mentioned by Marty Makary, Commissioner of the U.S. Food and Drug Administration (FDA) as a glaring example of how ...

WASHINGTON — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as ...